Quotes with Resistance & Support
Market Information

Alembic Q3FY08 sales at Rs 265cr up 39%

This article was posted on Jan 25, 2008 and is filed under Press Releases

Alembic Limited reported a net profit of Rs 42 crore for the quarter ended December 31, 2007, a jump of 67% as against Rs 25 crore posted in the same period of last fiscal. This includes Profit on sale of surplus land amounting to Rs. 22.55 crore.

Sales for the third quarter stood at Rs 265 crore, a growth of 39 % as compared to Rs 191 crore in the third quarter of the corresponding previous year. Earnings per Share (EPS) for Q3 FY – 08 worked out to Rs 3.04 as compared to Rs 1.81 in Q3 FY – 07.

Sales for the nine months ended December 31, 2007 grew by 37 % to Rs 759 crore compared to Rs 552 crore in the year-ago period, while net profit for the nine-months period to December 31, 2007 rose by 62% to Rs 97 crore, as against Rs 60 crore posted in same period of last fiscal.

The Company’s sales to regulated markets in the quarter was significantly higher at Rs. 59 crore against Rs. 11 crore in corresponding quarter for the previous year.

The Company’s API facility was successfully re-inspected by USFDA. The Company’s formulation facility at Panelav also got successfully inspected by USFDA.With effect from 1st January, 2008 Alembic has acquired API manufacturing unit for its regulatory fillings for a consideration of Rs. 17.50 crore.

Sourced From: Adfactors Public Relations Pvt Ltd

Tags: , , , ,

Similar Posts:


+ve 30 DMA    50 DMA    150 DMA    200 DMA
-ve 30 DMA    50 DMA    150 DMA    200 DMA

Latest Query

Samrudhiglobal.com wishing you and your friends and family Advance xmas and Happy New year...view more »
- by Sam
Status: Awaiting reply

Market Stats

Search Our Archives

Latest Investment Idea

Recent Comments